Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -2.953M
March 31, 2026 -2.914M
December 31, 2025 -1.85M
September 30, 2025 -2.868M
June 30, 2025 -2.802M
March 31, 2025 -1.836M
December 31, 2024 -1.174M
September 30, 2024 -0.246M
June 30, 2024 -1.043M
March 31, 2024 -1.946M
December 31, 2023 -8.715M
September 30, 2023 -5.78M
Date Value
June 30, 2023 -5.372M
March 31, 2023 -5.339M
December 31, 2022 -0.866M
September 30, 2022 -1.514M
June 30, 2022 -0.218M
March 31, 2022 -0.055M
December 31, 2021 -0.332M
September 30, 2021
June 30, 2021
March 31, 2021 0.00
December 31, 2020 -0.009M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Insulet Corp. -37.40M
Abbott Laboratories -673.00M
Globus Medical, Inc. -129.05M
Stryker Corp. -639.00M
Baxter International, Inc. -117.00M